Michael Shetzline
SVP, CMO, Head-Res&Drug · 2 filings · Latest: Mar 10, 2026
IRONWOOD PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IRWD | Michael Shetzline | SVP, CMO, Head-Res&Drug | Feb 24, 2026 | Sale | $3.66 | 17,012 | $62.3K | 521,425 | |
IRWD | Michael Shetzline | SVP, CMO, Head-Res&Drug | Feb 23, 2026 | Sale | $3.81 | 15,570 | $59.3K | 538,437 | |
IRWD | Shetzline Michael | — | Feb 23, 2026 | Proposed Sale | $4.61 | 29,937 | $138.0K | — | |
IRWD | Shetzline Michael | — | Feb 10, 2025 | Proposed Sale | $1.94 | 42,274 | $82.0K | — |